Abstract Phenotypic variation in bone mineral density (BMD) among healthy adults is influenced by both genetic and environmental factors. Sequence variations in the adenylate cyclase 10 (ADCY10) gene, which is also called soluble adenylate cyclase, have previously been associated with low spinal BMD in hypercalciuric patients. Since ADCY10 is located in the region linked to spinal BMD in our previous linkage analysis, we tested whether polymorphisms in this gene are also associated with normal BMD variation in healthy adults. Sixteen single-nucleotide polymorphisms (SNPs) distributed throughout ADCY10 were genotyped in two healthy groups of American whites: 1692 premenopausal women and 715 men. Statistical analyses were performed in the two groups to test for association between these SNPs and the femoral neck and lumbar spine areal BMD. We observed significant evidence of association (p \ 0.01), with one SNP each in men and women. Genotypes at these SNPs accounted for \1% of hip BMD variation in men but 1.5% of spinal BMD in women. However, adjacent SNPs did not corroborate the association in either men or women. In conclusion, we found a modest association between an ADCY10 polymorphism and the spinal areal BMD in premenopausal white women.
Adenylate cyclase synthesizes cyclic adenosine monophosphate, a second messenger involved in a number of biological processes. A soluble form, ADCY10, is expressed in many tissues, including bone (osteoblast) and kidney [17] [18] [19] . Although its role in bone is unclear, the association of genetic variation in ADCY10 with low spinal BMD in hypercalciuric patients [17] and its genomic location within a region linked to spinal BMD in healthy women [7, 8] suggest that this gene may contribute to the variation of BMD in the normal population. Thus, we investigated whether polymorphisms in ADCY10 are associated with normal variation in peak BMD in a sample of healthy men and premenopausal women.
Subjects and Methods

Sample
Families consisting of healthy siblings were recruited from the state of Indiana (Table 1) [6, 7] . Recruitment focused on families with two or more healthy sisters (n = 766) or brothers (n = 336). Families meeting both criteria (at least two healthy sisters and two healthy brothers) were also included (n = 26). In addition, 633 parents of the sisters and 233 parents of the brothers participated in this study. Studies were performed at the General Clinical Research Center of Indiana University School of Medicine. Both the sister and the brother studies were approved by the Institutional Review Board of Indiana University-Purdue University Indianapolis. Informed written consent was obtained from all subjects prior to their participation in the study.
Health and lifestyle questionnaires were administered. The sample of sisters ranged in age from 20 to 51 years. Sisters were required to be within 10 years of each other in age. Women who had irregular menses or a history of pregnancy or lactation within 3 months prior to enrollment were excluded. Women taking oral contraceptives were not excluded. The sample of brothers ranged in age from 18 to 61 years. There was no exclusion based on the difference in age between the brothers. Exclusion criteria for both sisters and brothers included a history of chronic disease, use of medications known to affect bone mass or metabolism, and an inability to measure BMD because of obesity.
Our linkage finding in chromosome 1q was in American white sisters, and the original findings by Reed et al. [17] were in Caucasian. Therefore, we limited the scope of this study to only include our American white samples.
BMD, Height, and Weight Measurements
Areal BMD at the lumbar spine (vertebrae L2-L4) and femoral neck were measured by dual-energy X-ray absorptiometry (DXA), using two DPX-L and one Prodigy instrument (GE Lunar Corp., Madison, WI). All three DXA instruments were cross-calibrated weekly using a stepwedge phantom. There was no detectable systematic difference among the three machines over the course of the study. The coefficient of variation on duplicate measurements after repositioning was 1.0% for femoral neck and 0.52% for lumbar spine. Siblings were measured on the same instrument. Height and weight were measured using a Harpenden stadiometer and a Scale-Tronix weighing scale, which were calibrated regularly.
Single-Nucleotide Polymorphism (SNP) Genotyping ADCY10 has 33 exons and spans 104 kb [17] . To ensure appropriate coverage of the entire gene, 16 SNPs distributed across ADCY10 (including at least 3 kb upstream and downstream of the gene) were selected for genotyping. Most of these SNPs were selected using SNP Tagger [20] by setting the minor allele frequency in the CEPH Utah population to be at least 0.2 in the HapMap Genome Browser. Based on their potential functional importance, three exonic SNPs were also included. Genotyping of SNPs was performed using iPLEX genotyping assays on a MassARRAY platform (Sequenom Inc., San Diego, CA). The SNPs were also genotyped in the available parental DNA to identify Mendelian inconsistencies in the SNP genotypes, using the program PedCheck [21] . Using one randomly selected individual in each family, each SNP was tested for a significant (p \ 0.001) deviation from HardyWeinberg equilibrium. The average rate for missing SNP genotypes was 3.6%, with a range of 0.9-8.1%.
Statistical Analyses
In this sample of men and women, only age and weight are significant covariates of BMD [6, 7] . Therefore, regression Note: Age, height, weight, and BMD values are mean ± SD residuals, representing age-and weight-adjusted BMD, were computed separately in men and women and used in all subsequent analyses. The presence of genetically distinct subgroups within a sample, termed population stratification, can increase the likelihood of a false-positive association. This is particularly true when a sample of unrelated individuals is analyzed. Since genotypic data from 402 microsatellite markers were available from a previously completed 10-cM genome screen [6] , we tested for population stratification in our sample using the program Structure [22] . A sample consisting of only one member from each of the genome-screened American white families (n = 982) was tested for stratification.
The program Haploview [23] was employed to examine the extent of linkage disequilibrium (LD) between the SNPs to ensure that the SNP density was sufficient to evaluate evidence of association. LD (R 2 statistic) was calculated using one randomly selected individual in each family. SNP Tagger [20] (http://www.broad.mit.edu/mpg/tagger/) was used to estimate how well the selected SNPs represented the genetic information contained in nongenotyped SNPs in the ADCY10 region. The extent to which the genotyped SNPs correlated with all HapMap SNPs in the ADCY10 region was evaluated for different levels of LD, with the R 2 statistic. A population-based association test was performed using a linear mixed model framework. SNP genotype was modeled as a fixed effect (taking on three levels corresponding to the observed genotypes), and family (sibship) as a random effect in the mixed model. Correlation between subjects in the same family was modeled by assuming an error covariance matrix exhibiting compound symmetry. The model was fitted using the MIXED procedure in the SAS statistical software (version 9.1). The mixed model association test employs data from all siblings with both genotype and phenotype. The proportion of BMD variation explained by each SNP was estimated by the R 2 measure for the mixed model framework [24] . This measure is analogous to the common R 2 measure in traditional ANOVA. Given the large size of our samples, we employed a stringent threshold of p \ 0.01 to ensure that we detected robust evidence of association and a clinically significant portion of the BMD variability.
Results
Analysis with the program Structure [22] indicated that there was no evidence of population stratification. The mean probability of classification into the group was 0.99. Mean ages in women and men were similar, but men were heavier and taller (Table 1) . Mean femoral neck BMD was higher in men than women, although BMD at lumbar spine was similar.
Sixteen SNPs were genotyped throughout ADCY10, including upstream and downstream flanking regions (Fig. 1, Table 2 ). There was no deviation (p \ 0.001) from Hardy-Weinberg equilibrium for any of the SNPs. LD between adjacent SNPs was moderate (Fig. 2) . However, the patterns of LD were consistent with those found in the HapMap sample of Utah residents with ancestry from northern and western Europe [25] . Further, the 16 SNPs genotyped in this study captured the genotypic information (with an R 2 C 0.5) contained in 78% of all ADCY10 SNPs genotyped in the HapMap Utah sample that have a minor allele frequency C0.05.
Among the 16 SNPs analyzed, only one SNP yielded positive evidence for association in each gender (p \ 0.01; Table 2 ). In the sister sample, rs16859886 was associated with spinal BMD (p = 0.00083), with an estimated effect size (R 2 ) of 1.5%. Women with at least one copy of the A allele at this SNP had lower BMD than those with the GG genotype ( Table 3 ). In the brother sample, rs203818 was associated with hip BMD (p = 0.0039, R 2 \ 1%) and showed a trend for association with spinal BMD (p = 0.077). Men homozygous for the AA genotype had significantly higher hip BMD compared to those with at least one G allele (Table 4) .
Discussion
We previously detected linkage of spinal BMD to chromosome 1q in a sample of premenopausal American white women [7, 8] . ADCY10 is an excellent positional candidate gene in the linked region due to its reported association with low BMD among hypercalciuric patients [17] . Based on these findings, we tested 16 sequence variations in ADCY10 for association with BMD in healthy American white men and women. Our study design had 80% power to detect an association accounting for 1.5% of the variation in BMD in women, with an a of 0.01, and an association accounting for 2.1% of BMD variability in men.
Only one SNP met the stringent significance level for association (p \ 0.01) in each gender. SNP rs203818 was associated with hip BMD in men, but the effect size was small (R 2 \ 1%). The significant association detected in women was with SNP rs16859886, the same nonsynonymous SNP in exon 7 (Thr234Met) that was associated with hypercalciuria and low BMD in the earlier study [17] . However, more polymorphic SNPs nearby (intron 7 and upstream of ADCY10) did not show any evidence of association. We estimated that the genotypes at SNP rs16859886 account for 1.5% of the variation in lumbar spine BMD in women. This effect size is moderately clinically significant. These data suggest that functional genetic variations in ADCY10 might affect BMD, although the function of ADCY10 in bone accrual is not clear. It is also possible that the variations in ADCY10 may cause mild calcium wasting in urine, which could lead to the subsequent low BMD in the general population. Regardless, given the relatively modest effect size, the findings in this study do not likely explain our previous linkage between chromosome 1q and spinal BMD in premenopausal white sisters [7, 8] It is interesting to speculate why variations in ADCY10 were significantly associated with spinal BMD in the earlier study [17] but explain a smaller proportion of the BMD variability in our sample of healthy women. The original association with spinal BMD was found in a sample of 45 hypercalciuric patients. This small sample size may have resulted in the overestimation of effect size in the earlier study. SNP rs16859886 is relatively uncommon in the European American population (minor allele frequency [MAF] = 0.08 in our sample, MAF = 0.11 in the HapMap CEU sample). Therefore, it is also possible that this SNP is in LD with a relatively rare variant that might contribute to BMD variation in hypercalciuric patients but accounts for only a small proportion of BMD variation in the general American white population.
This study had several strengths. There was no evidence of stratification in our sample. Further, we genotyped 16 SNPs distributed throughout the coding region of ADCY10 and also extended upstream and downstream of the gene. This allowed us to evaluate the evidence of association anywhere within the gene. All analyses were performed in men and women separately because of the sex-specific linkages detected for BMD. We also employed rigorous statistical criteria to limit the likelihood of a false-positive result. In summary, we have evaluated the evidence for association between 16 SNPs in ADCY10 and variation in areal BMD in both male and female study populations. We detected the most significant association between one nonsynonymous SNP and lumbar spine BMD variation in women, but the effect of the SNP genotypes on BMD was modest. We interpret these data to suggest that variation in ADCY10 may have a modest effect on peak spinal BMD in women. Results of the previous study [17] and the present study warrant additional replication in other populations. 
